News | Embolic Protection Devices | May 08, 2018

Sentinel Cerebral Protection System Reduces TAVR Strokes More Than 60 Percent

Device captures debris in 99 percent of patients undergoing TAVR

Sentinel Cerebral Protection System Reduces TAVR Strokes More Than 60 Percent

May 8, 2018 — One-year results from the Sentinel Cerebral Protection System show it can reduce the incidence of stroke during transcatheter aortic valve replacement (TAVR) by more than 60 percent. Since its clearance by the U.S. Food and Drug Administration (FDA) a year ago, the technology is now used by more than 10 percent of TAVR centers nationwide, according to manufacturer Claret Medical.

The Sentinel Cerebral Protection System protects patients by filtering, capturing and removing pieces of tissue, calcium and other harmful debris released during TAVR before it can reach the brain. Such debris could cause a blockage, potentially leading to a stroke. Studies have shown that the Sentinel technology captures debris in 99 percent of patients undergoing TAVR and has no safety risks associated with it.

Sentinel patient Jim McCutchon of Corpus Christi, Texas said, “Having aortic stenosis is like flirting with sudden death. My aortic valve was closing down slowly, and I had to stop to catch my breath even with no greater exercise than a leisurely walk. I needed TAVR, but I was concerned that I would have a stroke if I had TAVR without cerebral protection. I struggled with a three-year wait until Sentinel was available, and then I felt confident to move forward with the procedure. I’ve seen pictures of the debris that Sentinel captured on the way to my brain, and I am thankful that I waited. Since then, I have had no problems, and I can run and play again.”

“We would never drive a car without a seatbelt and we should never do TAVR without embolic protection,” said Susheel Kodali, M.D., from New York-Presbyterian Hospital.

“Stroke destroys lives, and it is important that we as physicians do all we can to prevent it. With this in mind, we now use Sentinel technology in all our TAVR cases and have been able to provide greater brain protection to patients,” said Samir Kapadia, M.D., with the Cleveland Clinic.

For more information: www.claretmedical.com

 

Related Content

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone.

Feature | Cath Lab | May 14, 2021 | By Dave Fornell, Editor
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal fun
Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting proc

Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Cath Lab | May 12, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.

Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images

Getty Images

News | Cath Lab | May 03, 2021
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for sta
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
News | Cath Lab | April 29, 2021
April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American
There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

News | Cath Lab | April 28, 2021
April 28, 2021 – Results from a retrospective observational study, presented today at...
A cardiac cath lab at Henry Ford Hospital in Detroit. Photo by Dave Fornell

A cardiac cath lab complex PCI case at Henry Ford Hospital in Detroit. Photo by Dave Fornell

News | Cath Lab | April 28, 2021
Videos | Cath Lab | April 02, 2021
Corindus, a Siemens Healthineers company and a developer of vascular robotics, recently launched a new set of automat
Videos | Cath Lab | March 31, 2021
This is a quick example of clinical use of the Shockwave Medical Intravascular Lithotripsy system that uses sonic wav